Library

DOC

DOC is a psychedelic amphetamine of the DOx family, first synthesized in 1972 at the University of Alberta and later documented by Alexander Shulgin in PiHKAL (1991). It is characterized by its long duration, strong visual effects, and prominent stimulant properties. DOC is highly dose-sensitive and often sold on blotter paper. Its intense body load and potency make it particularly challenging for those inexperienced with psychedelics.

DOC molecular structure
DOC molecular structure diagram from the DrugsPRO substance library.

Also known as: 4-chloro-2,5-DMA

Classification

  • Chemical: Amphetamine
  • Chemical: Phenethylamine
  • Psychoactive: Psychedelic
  • Psychoactive: Stimulant
  • Tag: Common
  • Tag: Hallucinogen
  • Tag: Research-Chemical
  • Tag: Substituted amphetamine

Effects

  • Spontaneous Tactile Sensations
  • Stimulation
  • Nausea
  • Vasoconstriction
  • Pupil Dilation
  • Increased Blood Pressure
  • Empathy Love And Sociability Enhancement
  • Analysis Enhancement
  • Thought Acceleration
  • Time Distortion
  • Novelty Enhancement
  • Immersion Enhancement
  • Tactile Enhancement
  • Bodily Control Enhancement
  • Hallucinations
  • Drifting
  • Tracers
  • After Images

Routes of Administration

Oral

Dosage

  • Heavy: 5.0+ mg
  • Light: 1 – 1.5 mg
  • Common: 1.5 – 2 mg
  • Strong: 3.0–5.0 mg
  • Threshold: 0.5 – 1 mg

Duration

  • Onset: 0.5-2.5 h
  • Comeup: 2-3 h
  • Peak: 6-12 h
  • Offset: 8-20 h
  • After Effects: 6-24 h
  • Total Duration: 8-20 h

Insufflated

Dosage

  • Heavy: 3.5 – 4 mg
  • Light: 0.5 – 1 mg
  • Common: 1 – 2 mg
  • Strong: 2.5 – 3.5 mg
  • Threshold: 0.5 mg

Duration

  • Onset: 0-0.1 h
  • Comeup: 0.17-0.5 h
  • Peak: 2-6 h
  • Offset: 2-8 h
  • After Effects: 2-24 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

DOC - Treoir substaint DrugsPRO

DOC: DOC is a psychedelic amphetamine of the DOx family, first synthesized in 1972 at the University of Alberta and later documented by Alexander Shulgin in PiHKAL (1991). It is characterized by its long duration, strong visual effects, and prominent stimulant properties. DOC is highly dose-sensitiv

Related pages